Specifically, ERK cascade is overactivated when STAG2 is down-regulated in thyroid cancer cells, followed with suppression of HER3 transcription and RAS signaling to promote protein degradation of c-Myc via AKT/GSK3β signaling pathway. Here, AKT1 is linked to thyroid gland carcinoma.